GB8821056D0 - Oral magnesium & potassium compositions & use - Google Patents

Oral magnesium & potassium compositions & use

Info

Publication number
GB8821056D0
GB8821056D0 GB888821056A GB8821056A GB8821056D0 GB 8821056 D0 GB8821056 D0 GB 8821056D0 GB 888821056 A GB888821056 A GB 888821056A GB 8821056 A GB8821056 A GB 8821056A GB 8821056 D0 GB8821056 D0 GB 8821056D0
Authority
GB
United Kingdom
Prior art keywords
potassium compositions
oral magnesium
oral
magnesium
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB888821056A
Other versions
GB2209668B (en
GB2209668A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB8821056D0 publication Critical patent/GB8821056D0/en
Publication of GB2209668A publication Critical patent/GB2209668A/en
Application granted granted Critical
Publication of GB2209668B publication Critical patent/GB2209668B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB8821056A 1987-09-11 1988-09-08 Oral, sustained-release composition comprising potassium and magnesium Expired - Lifetime GB2209668B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9575087A 1987-09-11 1987-09-11

Publications (3)

Publication Number Publication Date
GB8821056D0 true GB8821056D0 (en) 1988-10-05
GB2209668A GB2209668A (en) 1989-05-24
GB2209668B GB2209668B (en) 1991-06-05

Family

ID=22253423

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8821056A Expired - Lifetime GB2209668B (en) 1987-09-11 1988-09-08 Oral, sustained-release composition comprising potassium and magnesium

Country Status (12)

Country Link
JP (1) JPH01100128A (en)
AU (1) AU619481B2 (en)
BE (1) BE1001842A3 (en)
CH (1) CH677612A5 (en)
DE (1) DE3830563A1 (en)
DK (1) DK501288A (en)
FR (1) FR2620334A1 (en)
GB (1) GB2209668B (en)
IT (1) IT1227010B (en)
LU (1) LU87331A1 (en)
NL (1) NL8802224A (en)
SE (1) SE8803125L (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015611A1 (en) * 1989-06-20 1990-12-27 Otsuka Pharmaceutical Co., Ltd. Potassium-supplementing preparation
US5132118A (en) * 1990-05-11 1992-07-21 Mills John A Treatment of exercise-induced pulmonary hemorrhage in animals
FI911038A (en) * 1991-03-01 1992-09-02 Slk Marketing Oy DRYCKPULVER.
US5460972A (en) * 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
FR2677546B1 (en) * 1991-06-12 1994-01-21 Fabienne Joanny THERAPEUTIC COMPOSITION FOR EXTENDED RELEASE OF MAGNESIUM.
DE4201504C2 (en) * 1992-01-21 1997-04-30 Protina Chemische Ges Mbh magnesium preparation
CN1090483C (en) * 1997-07-31 2002-09-11 谢理峰 Potassium and magnesium controlled-release tablet and producing method thereof
DE10158286B4 (en) * 2000-11-20 2007-08-02 Dehn, Michael C. Active substance storage layer material
DE10126405A1 (en) * 2001-05-22 2003-02-27 Trommsdorff Gmbh & Co Pharmaceutical preparation containing physiologically compatible potassium and magnesium salts and its use for the prophylaxis and / or therapy of QT prolongations
ATE485814T1 (en) * 2005-08-19 2010-11-15 Verla Pharm MAGNESIUM DELAYED RELEASE MICRO TABLETS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA73467B (en) * 1972-02-25 1973-10-31 Hoffmann La Roche Mineral salts containing preparation
GB1422193A (en) * 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions

Also Published As

Publication number Publication date
IT8848327A0 (en) 1988-09-08
DK501288D0 (en) 1988-09-09
AU2204388A (en) 1989-03-16
BE1001842A3 (en) 1990-03-20
IT1227010B (en) 1991-03-05
GB2209668B (en) 1991-06-05
JPH01100128A (en) 1989-04-18
FR2620334A1 (en) 1989-03-17
GB2209668A (en) 1989-05-24
AU619481B2 (en) 1992-01-30
LU87331A1 (en) 1989-10-26
DK501288A (en) 1989-03-12
SE8803125L (en) 1989-03-12
CH677612A5 (en) 1991-06-14
NL8802224A (en) 1989-04-03
SE8803125D0 (en) 1988-09-06
DE3830563A1 (en) 1989-03-30

Similar Documents

Publication Publication Date Title
PH25757A (en) Oral compositions
EP0363748A3 (en) Oral compositions
GB8811830D0 (en) Oral compositions
GB8904454D0 (en) Oral compositions
PH25851A (en) Oral compositions
HK91893A (en) Oral compositions
GB2187384B (en) Oral compositions
GB8811829D0 (en) Oral compositions
EP0371542A3 (en) Oral composition
EP0310372A3 (en) Dental composition
GB8801470D0 (en) Oral compositions
EP0311260A3 (en) Oral compositions
PH23369A (en) Oral compositions
AR243379A1 (en) Oral compositions
GB8713040D0 (en) Oral compositions
ZA898598B (en) Oral compositions
GB8821056D0 (en) Oral magnesium & potassium compositions & use
GB8813576D0 (en) Composition & use
GB8723116D0 (en) Oral compositions
ZA887850B (en) Oral compositions
EP0255210A3 (en) Oral composition
GB8723117D0 (en) Oral compositions
GB8924295D0 (en) Oral compositions
ZA884171B (en) Oral compositions
IE871517L (en) Oral compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19920908